Acute Responses to Walking, Stair Climbing, and Functional Circuit Exercise
4 septembre 2026 mis à jour par: Ramazan Bayer, Malatya Turgut Ozal University
Acute Metabolic, Respiratory, and Neuromotor Responses to Walking, Stair Climbing, and Functional Circuit Exercise in Sedentary Individuals: A Heart Rate-Controlled Randomized Crossover Study
This study evaluated the acute physiological responses to three different exercise modalities in sedentary young men. Participants completed walking, stair climbing, and functional circuit exercise sessions in a randomized crossover design. Each exercise session lasted 20 minutes and was performed at a target intensity of 50% heart rate reserve (±5 beats/min), with at least 72 hours between sessions.
The study compared acute respiratory, metabolic, and neuromotor responses to the three exercise modalities. Pulmonary function was assessed using spirometry, blood lactate concentration was measured using capillary blood samples, and countermovement jump performance was assessed as an indicator of neuromuscular performance. Heart rate was continuously monitored during each exercise session.
Aperçu de l'étude
Statut
Complété
Les conditions
Type d'étude
Interventionnel
Inscription (Réel)
30
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Malatya
-
Malatya, Malatya, Turquie (Türkiye), 44100
- Malatya Turgut Ozal University
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- Male sex.
- Aged 18-30 years.
- Classified as sedentary/insufficiently active according to the study eligibility criteria.
- Able to safely complete the exercise protocols and study assessments.
- Provided voluntary informed consent.
Exclusion Criteria:
- Current cigarette or electronic cigarette use.
- Known cardiovascular, respiratory, or metabolic disease.
- Regular medication use that could affect physiological responses to exercise.
- Acute infection within the previous 2 weeks.
- Musculoskeletal conditions that could interfere with safe participation in the exercise protocols.
- Any condition requiring medical evaluation before exercise participation.
- Inability to obtain acceptable baseline spirometry measurements according to the study procedures.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: WP-SP-FCP Sequence
Participants completed the Walking Protocol first, followed by the Stair Climbing Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
|
|
Expérimental: WP-FCP-SP Sequence
Participants completed the Walking Protocol first, followed by the Functional Circuit Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
|
|
Expérimental: SP-WP-FCP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Walking Protocol and then the Functional Circuit Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
|
|
Expérimental: SP-FCP-WP Sequence
Participants completed the Stair Climbing Protocol first, followed by the Functional Circuit Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
|
|
Expérimental: FCP-WP-SP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Walking Protocol and then the Stair Climbing Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
|
|
Expérimental: FCP-SP-WP Sequence
Participants completed the Functional Circuit Protocol first, followed by the Stair Climbing Protocol and then the Walking Protocol, with at least 72 hours between sessions.
|
Participants performed a 20-minute walking exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute stair climbing exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
Participants performed a 20-minute functional circuit exercise session at a target intensity of 50% heart rate reserve (HRR), maintained within ±5 beats/min of the individual target heart rate.
The circuit consisted of chair sit-to-stand, reverse lunges, wall push-ups, high-knee marching, and low-impact mountain climbers performed on an elevated surface.
Heart rate was continuously monitored throughout the exercise session.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Forced Expiratory Volume in One Second (FEV1)
Délai: Baseline and 5 minutes after each exercise session
|
Forced expiratory volume in one second (FEV1) was measured by spirometry before and 5 minutes after each exercise condition.
The primary outcome was the change in FEV1 (ΔFEV1), calculated as post-exercise FEV1 minus pre-exercise FEV1 and expressed in liters (L).
Measurements were obtained following standardized spirometry procedures.
|
Baseline and 5 minutes after each exercise session
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Forced Vital Capacity (FVC)
Délai: Baseline and 5 minutes after each exercise session
|
Forced vital capacity (FVC) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FVC (ΔFVC), calculated as post-exercise FVC minus pre-exercise FVC and expressed in liters (L).
|
Baseline and 5 minutes after each exercise session
|
|
Change in FEV1/FVC Ratio
Délai: Baseline and 5 minutes after each exercise session
|
The FEV1/FVC ratio was assessed by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in FEV1/FVC ratio (ΔFEV1/FVC), calculated as the post-exercise value minus the pre-exercise value.
|
Baseline and 5 minutes after each exercise session
|
|
Change in Peak Expiratory Flow (PEF)
Délai: Baseline and 5 minutes after each exercise session
|
Peak expiratory flow (PEF) was measured by spirometry before and 5 minutes after each exercise condition.
The outcome was the change in PEF (ΔPEF), calculated as the post-exercise PEF minus the pre-exercise PEF and expressed in liters per second (L/s).
|
Baseline and 5 minutes after each exercise session
|
|
Change in Blood Lactate Concentration
Délai: Baseline and 3 minutes after each exercise session
|
Capillary blood lactate concentration was measured before exercise and 3 minutes after each exercise condition.
The outcome was the change in blood lactate concentration (ΔLactate), calculated as the post-exercise value minus the pre-exercise value and expressed in millimoles per liter (mmol/L).
|
Baseline and 3 minutes after each exercise session
|
|
Change in Countermovement Jump Height (CMJ)
Délai: Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
Countermovement jump (CMJ) height was assessed before and after each exercise condition.
The outcome was the change in CMJ height (ΔCMJ), calculated as the post-exercise value minus the pre-exercise value and expressed in centimeters (cm).
|
Baseline and immediately after post-exercise spirometry initiated at 5 minutes after each exercise session
|
|
Mean Heart Rate During Exercise
Délai: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Mean heart rate was calculated across the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Maximum Heart Rate During Exercise
Délai: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
Maximum heart rate was defined as the highest heart rate recorded during the exercise period and expressed in beats per minute (bpm).
|
During each 20-minute exercise session
|
|
Time Spent in the Target Heart Rate Range
Délai: During each 20-minute exercise session
|
Heart rate was continuously monitored throughout each exercise condition.
The outcome was the percentage of exercise time during which heart rate remained within ±5 beats/min of the individualized target heart rate corresponding to 50% heart rate reserve (HRR)
|
During each 20-minute exercise session
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
22 juin 2026
Achèvement primaire (Réel)
5 août 2026
Achèvement de l'étude (Réel)
5 août 2026
Dates d'inscription aux études
Première soumission
1 septembre 2026
Première soumission répondant aux critères de contrôle qualité
4 septembre 2026
Première publication (Réel)
8 septembre 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
8 septembre 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
4 septembre 2026
Dernière vérification
1 septembre 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2026/205
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Description du régime IPD
Individual participant data are not planned to be shared because no data-sharing plan was established as part of the original study protocol.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .